Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone for Endometriosis Pain
NCT03970330Phase 3Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jan 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometriosis comparing Low-Dose Naltrexone with Placebo (2 arms). Primary endpoint: Pain Score Area Under the Curve at 12 weeks. Started Jan 2020; status: terminated.
02
Drugs
naltrexone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03970330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970330.